These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 18669208)

  • 21. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
    Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The participation of the brain dopamine D1 and D2 receptors in the process of the development of depression induced by social confrontations in mice].
    Alekseenko OV; Avgustinovich DF; Lipina TV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1998; 48(6):1090-8. PubMed ID: 9929919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders.
    Wood MD; Wren PB
    Prog Brain Res; 2008; 172():213-30. PubMed ID: 18772035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacotherapy of depression: recent developments].
    Baumann P
    Rev Med Suisse; 2007 Sep; 3(125):2079-80, 2083-4. PubMed ID: 17939526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dopaminergic drugs in the treatment of depression].
    Burmester D; von Buchwald CM; Videbech P
    Ugeskr Laeger; 2021 Nov; 183(47):. PubMed ID: 34851261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antidepressants of the future: role of the glutamatergic system].
    Pitchot W; Scantamburlo G; Ansseau M
    Rev Med Liege; 2011 Apr; 66(4):195-8. PubMed ID: 21638837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The neurobiology of depression].
    Haffen E; Sechter D
    Rev Prat; 1999 Apr; 49(7):707-12. PubMed ID: 10337213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic implication of cocaine- and amphetamine-regulated transcript (CART) in the treatment of depression.
    Pae CU; Lee C; Paik IH
    Med Hypotheses; 2007; 69(1):132-5. PubMed ID: 17196760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs and depression.
    Mouillet-Richard S; Baudry A; Launay JM; Kellermann O
    Neurobiol Dis; 2012 May; 46(2):272-8. PubMed ID: 22226785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine receptor agonists and depression in Parkinson's disease.
    Picillo M; Rocco M; Barone P
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S81-4. PubMed ID: 20123564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of dopaminergic and stimulant drugs for the treatment of depression.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Feb; 50(2):11-4. PubMed ID: 22263621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The keys to improving depression outcomes.
    Rizvi SJ; Kennedy SH
    Eur Neuropsychopharmacol; 2011 Sep; 21 Suppl 4():S694-702. PubMed ID: 21924209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applying neuropharmacy when treating patients with depression.
    Ashton AK; D'Mello DA; Dantz B; Hefner J; Leon FG; Matson GA; Montano CB; Pradko JF; Sussman N; Winsberg B
    J Fam Pract; 2003 Dec; Suppl():S34-9. PubMed ID: 14693076
    [No Abstract]   [Full Text] [Related]  

  • 35. [Monoamine's role in depression and possible consequences for the clinical management of the core symptoms of major depression].
    La Pia S
    Riv Psichiatr; 2009; 44(1):1-14. PubMed ID: 20066933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pramipexole is active in depression tests and modulates monoaminergic transmission, but not brain levels of BDNF in mice.
    Schulte-Herbrüggen O; Vogt MA; Hörtnagl H; Gass P; Hellweg R
    Eur J Pharmacol; 2012 Feb; 677(1-3):77-86. PubMed ID: 22206815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research and treatment approaches to depression.
    Wong ML; Licinio J
    Nat Rev Neurosci; 2001 May; 2(5):343-51. PubMed ID: 11331918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel strategies for pharmacotherapy of depression.
    Maubach KA; Rupniak NM; Kramer MS; Hill RG
    Curr Opin Chem Biol; 1999 Aug; 3(4):481-8. PubMed ID: 10419849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is depression associated with dysfunction of the central reward system?
    Martin-Soelch C
    Biochem Soc Trans; 2009 Feb; 37(Pt 1):313-7. PubMed ID: 19143654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidepressant-like effect of creatine in mice involves dopaminergic activation.
    Cunha MP; Machado DG; Capra JC; Jacinto J; Bettio LE; Rodrigues AL
    J Psychopharmacol; 2012 Nov; 26(11):1489-501. PubMed ID: 22674968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.